Investors Are Undervaluing Kindred Healthcare Inc (NYSE:KND) By 34%

In this article:

How far off is Kindred Healthcare Inc (NYSE:KND) from its intrinsic value? Using the most recent financial data, I am going to take a look at whether the stock is fairly priced using the discounted cash flows (DCF) model. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model. Also note that this article was written in April 2018 so be sure check the latest calculation for Kindred Healthcare here.

Crunching the numbers

We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second ‘steady growth’ period. To begin, I use the analyst consensus estimates of KND’s levered free cash flow (FCF) over the next five years and discounted these values at the cost of equity of 17.53%. When estimates weren’t available, I’ve extrapolated the average annual growth rate over the previous five years, capped at a reasonable level. This resulted in a present value of 5-year cash flow of US$583.39M. Keen to know how I arrived at this number? Check out our detailed analysis here.

NYSE:KND Future Profit Apr 11th 18
NYSE:KND Future Profit Apr 11th 18

Above is a visual representation of how KND’s top and bottom lines are expected to move in the future, which should give you an idea of KND’s outlook. Secondly, I determine the terminal value, which accounts for all the future cash flows after the five years. It’s appropriate to use the 10-year government bond rate of 2.8% as the perpetual growth rate, which is rightly below GDP growth, but more towards the conservative side. Discounting the terminal value back five years gives us a present value of US$635.80M.

The total value, or equity value, is then the sum of the present value of the cash flows, which in this case is US$1.22B. To get the intrinsic value per share, we divide this by the total number of shares outstanding. This results in an intrinsic value of $13.34, which, compared to the current share price of $8.85, we find that Kindred Healthcare is quite good value at a 33.64% discount to what it is available for right now.

Next Steps:

Whilst important, DCF calculation shouldn’t be the only metric you look at when researching a company. What is the reason for the share price to differ from the intrinsic value? For KND, I’ve compiled three pertinent factors you should further examine:

  1. Financial Health: Does KND have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.

  2. Future Earnings: How does KND’s growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.

  3. Other High Quality Alternatives: Are there other high quality stocks you could be holding instead of KND? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. The Simply Wall St app conducts a discounted cash flow for every stock on the NYSE every 6 hours. If you want to find the calculation for other stocks just search here.


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.

Advertisement